PL2427177T3 - Kompozycja do przedłużonego podawania leku zawierająca geopolimerowy środek wiążący - Google Patents

Kompozycja do przedłużonego podawania leku zawierająca geopolimerowy środek wiążący

Info

Publication number
PL2427177T3
PL2427177T3 PL10718263T PL10718263T PL2427177T3 PL 2427177 T3 PL2427177 T3 PL 2427177T3 PL 10718263 T PL10718263 T PL 10718263T PL 10718263 T PL10718263 T PL 10718263T PL 2427177 T3 PL2427177 T3 PL 2427177T3
Authority
PL
Poland
Prior art keywords
composition
drug delivery
sustained drug
geopolymeric binder
geopolymeric
Prior art date
Application number
PL10718263T
Other languages
English (en)
Inventor
Håkan ENGQVIST
Original Assignee
Emplicure Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Emplicure Ab filed Critical Emplicure Ab
Publication of PL2427177T3 publication Critical patent/PL2427177T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL10718263T 2009-05-08 2010-05-07 Kompozycja do przedłużonego podawania leku zawierająca geopolimerowy środek wiążący PL2427177T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SE0900626 2009-05-08
SE1000117 2010-02-08
EP10718263.6A EP2427177B1 (en) 2009-05-08 2010-05-07 Composition for sustained drug delivery comprising geopolymeric binder
PCT/GB2010/000910 WO2010128300A1 (en) 2009-05-08 2010-05-07 Composition for sustained drug delivery comprising geopolymeric binder

Publications (1)

Publication Number Publication Date
PL2427177T3 true PL2427177T3 (pl) 2018-09-28

Family

ID=42638663

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10718263T PL2427177T3 (pl) 2009-05-08 2010-05-07 Kompozycja do przedłużonego podawania leku zawierająca geopolimerowy środek wiążący

Country Status (15)

Country Link
US (2) US9486527B2 (pl)
EP (1) EP2427177B1 (pl)
JP (1) JP5691051B2 (pl)
KR (1) KR101830080B1 (pl)
CN (1) CN102421419B (pl)
AU (1) AU2010244194B2 (pl)
BR (1) BRPI1011412A8 (pl)
CA (1) CA2761000C (pl)
DK (1) DK2427177T3 (pl)
EA (1) EA027618B1 (pl)
ES (1) ES2673196T3 (pl)
IL (1) IL215826A (pl)
MX (1) MX2011011829A (pl)
PL (1) PL2427177T3 (pl)
WO (1) WO2010128300A1 (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2427177T3 (pl) * 2009-05-08 2018-09-28 Emplicure Ab Kompozycja do przedłużonego podawania leku zawierająca geopolimerowy środek wiążący
US12186426B2 (en) 2009-10-30 2025-01-07 Ix Biopharma Ltd. Solid dosage form
TR201902233T4 (tr) 2009-10-30 2019-03-21 Ix Biopharma Ltd Hızlı çözünen katı dozaj formu.
UA102627C2 (uk) * 2012-03-20 2013-07-25 Общество С Ограниченной Ответственностью "Наномедтраст" Нанокомпозит оксид церію-алюмосилікатні трубки та спосіб його отримання
IN2014DN09416A (pl) 2012-04-25 2015-07-17 Spi Pharma Inc
WO2014011830A1 (en) 2012-07-12 2014-01-16 Mallinckrodt Llc Extended release, abuse deterrent pharmaceutical compositions
CN105050708A (zh) 2012-11-14 2015-11-11 格雷斯公司 含有生物活性材料与无序无机氧化物的组合物
US20140194328A1 (en) 2013-01-07 2014-07-10 Vince Alessi Thermoset ceramic compositions and a method of preparation therefor
WO2017149288A1 (en) * 2016-02-29 2017-09-08 Emplicure Ab Devices for evaporation and inhalation of nicotine
CN105997907A (zh) * 2016-05-16 2016-10-12 胡小丽 高血压治疗药丸
CN105769798A (zh) * 2016-05-16 2016-07-20 张阳 一种高血压治疗药物的制备方法
CN105997915A (zh) * 2016-05-16 2016-10-12 张阳 一种高血压治疗用缓释片剂
KR102007278B1 (ko) 2017-01-19 2019-08-06 가톨릭대학교 산학협력단 바이러스 진단 및 치료를 위한 인지능 물질 및 이의 제조방법

Family Cites Families (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0391893B1 (en) 1983-11-14 1993-08-25 The University of Kentucky Research Foundation Porous microspheres for drug delivery and methods for making same
EP0265061B1 (en) 1986-09-18 1992-01-08 London School of Pharmacy Innovations Ltd Pharmaceutical formulation
IT1197316B (it) 1986-10-01 1988-11-30 Proter Spa Formulazione galenica ad uso orale di derivati della reina a lento rilascio per impiego terapeutico
JP2702953B2 (ja) 1988-01-30 1998-01-26 オリンパス光学工業株式会社 薬液含浸セラミックス
IT1216570B (it) 1988-04-08 1990-03-08 Vectorpharma Int Composizione farmaceutiche a rilascio controllato e procedimento per la loro preparazione.
JPH01268104A (ja) * 1988-04-20 1989-10-25 Matsushita Electric Works Ltd チョークコイル
JPH0230988A (ja) 1988-07-20 1990-02-01 Toshiba Corp 宇宙軌道上発電プラント
JPH02268104A (ja) 1989-04-07 1990-11-01 Kanebo Ltd 抗菌性組成物
US5443812A (en) 1989-04-24 1995-08-22 Kanebo Ltd. Stabilized synthetic zeolite and a process for the preparation thereof
JPH07188000A (ja) 1993-12-27 1995-07-25 Bridgestone Corp 薬用被覆材
JPH0930988A (ja) 1995-07-21 1997-02-04 Sumitomo Osaka Cement Co Ltd 薬剤徐放性多孔質セラミックス成形体及びその製造方法
GB2307862A (en) 1995-12-05 1997-06-11 David Jehan Patch structures for transdermal therapy
EP0947489A4 (en) 1996-11-25 2001-08-08 Advance Kk PROCESS FOR PRODUCING CERAMICS
US5902591A (en) 1997-04-03 1999-05-11 La Prairie Sa Stable topical cosmetic/pharmaceutical emulsion compositions containing ascorbic acid
US6503231B1 (en) 1998-06-10 2003-01-07 Georgia Tech Research Corporation Microneedle device for transport of molecules across tissue
US6123925A (en) * 1998-07-27 2000-09-26 Healthshield Technologies L.L.C. Antibiotic toothpaste
US6342249B1 (en) 1998-12-23 2002-01-29 Alza Corporation Controlled release liquid active agent formulation dosage forms
US6635281B2 (en) 1998-12-23 2003-10-21 Alza Corporation Gastric retaining oral liquid dosage form
US20030118641A1 (en) 2000-07-27 2003-06-26 Roxane Laboratories, Inc. Abuse-resistant sustained-release opioid formulation
AUPQ573300A0 (en) * 2000-02-21 2000-03-16 Australian Nuclear Science & Technology Organisation Controlled release ceramic particles, compositions thereof, processes of preparation and methods of use
US7011841B2 (en) 2000-03-24 2006-03-14 Mark B. Lyles High density porous materials
NZ521853A (en) 2000-04-11 2003-11-28 Sankyo Co Stabilized pharmaceutical compositions containing a calcium blocker
US20020122828A1 (en) 2001-03-02 2002-09-05 Jun Liu Hybrid porous materials for controlled release
CA2440069A1 (en) 2001-03-05 2002-09-12 Ortho-Mcneil Pharmaceutical, Inc. Taste masked pharmaceutical compositions
WO2003035135A1 (en) 2001-09-24 2003-05-01 Boston Scientific Limited Optimized dosing for drug coated stents
CA2461708C (en) 2001-09-28 2012-08-07 Nutraceutix, Inc. Delivery system for biological component
WO2003043657A1 (en) 2001-11-19 2003-05-30 Control Delivery Systems, Inc. Topical delivery of codrugs
DE60336394D1 (de) 2002-04-23 2011-04-28 Durect Corp Transdermale analgetische systeme mit reduziertem missbrauchspotential
WO2003092785A1 (en) 2002-04-30 2003-11-13 Morteza Shirkhanzadeh Arrays of microneedles comprising porous calcium phosphate coating and bioactive agents
WO2004024224A1 (en) 2002-09-16 2004-03-25 Sung-Yun Kwon Solid micro-perforators and methods of use
SE524334C2 (sv) 2002-09-30 2004-07-27 Cerbio Tech Ab Värmegenererande biokompatibla keramiska material och förfarande för dess framställning
SE525236C2 (sv) 2002-10-31 2005-01-11 Cerbio Tech Ab Förfarande för framställning av strukturerade keramiska beläggningar och belagda anordningar framställda med detta förfarande
SE524494C2 (sv) 2002-12-31 2004-08-17 Doxa Ab Kemiskt bundna biomaterialelement med skräddarsydda egenskaper
US20070258926A1 (en) * 2003-10-15 2007-11-08 Ltt Bio-Pharma Co., Ltd. Composition containing retinoic acid nanoparticles coated with inorganic salt of polyvalent metal
AU2004283644A1 (en) 2003-10-29 2005-05-06 Doxa Ab A two-step system for improved initial and final characteristics of a biomaterial
US20050181049A1 (en) 2003-11-19 2005-08-18 Dong Liang C. Composition and method for enhancing bioavailability
EP1708686B1 (en) 2003-12-31 2011-02-16 Cima Labs Inc. Generally linear effervescent oral fentanyl dosage form and methods of administering
JP4832082B2 (ja) 2004-02-03 2011-12-07 久光製薬株式会社 経皮薬物投与装置用インタフェース
US7315758B2 (en) 2004-06-03 2008-01-01 Lynntech, Inc. Transdermal delivery of therapeutic agent
KR101352299B1 (ko) 2004-06-28 2014-02-17 벨로시스 파마슈티컬스 에이/에스 액상 제형용 담체로서의 다공성 정제
WO2006017337A1 (en) 2004-07-13 2006-02-16 Altairnano, Inc. Ceramic structures for controlled release of drugs
AU2005271781A1 (en) 2004-07-13 2006-02-16 Altairnano, Inc. Ceramic structures for prevention of drug diversion
WO2006015299A2 (en) 2004-07-30 2006-02-09 Microchips, Inc. Multi-reservoir device for transdermal drug delivery and sensing
EP1791520A2 (en) 2004-08-19 2007-06-06 Alza Corporation Controlled release nanoparticle active agent formulation dosage forms and methods
US8535702B2 (en) 2005-02-01 2013-09-17 Boston Scientific Scimed, Inc. Medical devices having porous polymeric regions for controlled drug delivery and regulated biocompatibility
FR2881652B1 (fr) 2005-02-08 2007-05-25 Flamel Technologies Sa Forme pharmaceutique orale microparticulaire anti-mesuage
WO2006096544A1 (en) 2005-03-04 2006-09-14 Altairnano, Inc. Ceramic structures for controlled release of biologically active substances
DE102005040429A1 (de) 2005-08-25 2007-03-01 Heraeus Kulzer Gmbh Wirkstofffreisetzungssystem und seine Verwendung
US8652529B2 (en) 2005-11-10 2014-02-18 Flamel Technologies Anti-misuse microparticulate oral pharmaceutical form
US7682445B2 (en) 2005-12-08 2010-03-23 Doxa Ab Powdered CBC system with improved reaction feature
US20090104286A1 (en) 2005-12-29 2009-04-23 Robert Basic Regulation of allergic reaction
US20070212414A1 (en) 2006-03-08 2007-09-13 Penwest Pharmaceuticals Co. Ethanol-resistant sustained release formulations
US20070248656A1 (en) * 2006-04-25 2007-10-25 Galer Bradley S Topical preparation dispensers and methods of using the same
US9023400B2 (en) 2006-05-24 2015-05-05 Flamel Technologies Prolonged-release multimicroparticulate oral pharmaceutical form
DE102006028781A1 (de) 2006-06-23 2007-12-27 Robert Bosch Gmbh Verfahren zur Herstellung von porösen Mikronadeln und ihre Verwendung
US20080214987A1 (en) 2006-12-22 2008-09-04 Nanomed Devices, Inc. Microdevice And Method For Transdermal Delivery And Sampling Of Active Substances
WO2008105737A1 (en) 2007-03-01 2008-09-04 Doxa Ab Stable cement composition for orthopaedic and dental use
EP2131878A4 (en) 2007-03-01 2012-12-26 Doxa Ab INJECTABLE CEMENT COMPOSITION FOR ORTHOPEDIC AND DENTAL PURPOSES
WO2008105739A1 (en) 2007-03-01 2008-09-04 Doxa Ab Drug implant carrier for drug delivery
US20090061003A1 (en) 2007-03-28 2009-03-05 Doxa Ab Carriers for drug delivery
CN101104080B (zh) * 2007-04-24 2011-06-22 深圳市鸿华投资有限公司 沸石止血敷料及其制备方法和用途
GB0709541D0 (en) 2007-05-17 2007-06-27 Jagotec Ag Pharmaceutical excipient
EP2100850A1 (en) 2008-03-11 2009-09-16 Stichting Voor De Technische Wetenschappen Microneedle array and a method for manufacturing microneedles
WO2010096704A2 (en) 2009-02-19 2010-08-26 Alex Garfield Bonner Porous interpenetrating polymer network
PL2427177T3 (pl) * 2009-05-08 2018-09-28 Emplicure Ab Kompozycja do przedłużonego podawania leku zawierająca geopolimerowy środek wiążący
WO2012032337A2 (en) * 2010-09-07 2012-03-15 Orexo Ab A transdermal drug administration device

Also Published As

Publication number Publication date
US20170112932A1 (en) 2017-04-27
US10092652B2 (en) 2018-10-09
KR101830080B1 (ko) 2018-02-21
EP2427177B1 (en) 2018-03-28
EP2427177A1 (en) 2012-03-14
JP5691051B2 (ja) 2015-04-01
CA2761000A1 (en) 2010-11-11
CA2761000C (en) 2018-05-29
BRPI1011412A2 (pt) 2016-03-15
BRPI1011412A8 (pt) 2018-01-02
IL215826A0 (en) 2012-01-31
US20120252845A1 (en) 2012-10-04
DK2427177T3 (en) 2018-06-18
WO2010128300A1 (en) 2010-11-11
AU2010244194A1 (en) 2011-11-10
KR20120015344A (ko) 2012-02-21
EA201101596A1 (ru) 2012-05-30
ES2673196T3 (es) 2018-06-20
CN102421419B (zh) 2016-05-04
JP2012526091A (ja) 2012-10-25
IL215826A (en) 2016-11-30
US9486527B2 (en) 2016-11-08
CN102421419A (zh) 2012-04-18
AU2010244194B2 (en) 2014-12-04
MX2011011829A (es) 2012-02-21
EA027618B1 (ru) 2017-08-31

Similar Documents

Publication Publication Date Title
IL215826A0 (en) Composition for sustained drug delivery comprising geopolymeric binder
IL215608A0 (en) Drug delivery composition
IL207569A0 (en) Compositions and methods for drug delivery
IL216374A0 (en) Compositions and methods for drug delivery
HUE042850T2 (hu) Készítmények hatóanyag szállításra
ZA201304687B (en) Biodegradable drug delivery compositions
IL210590A0 (en) Progestin-cotaining drug delivery system
IL228817A0 (en) Pharmaceutical compounds
IL195764A0 (en) Compositions and methods for drug delivery
EP2010162A4 (en) COMPOSITION FOR DISPOSING A MEDICINAL PRODUCT
ZA201302120B (en) Biodegradable drug delivery composition
ZA201008584B (en) A pharmaceutical composition comprising rebamipide
PL394605A1 (pl) Trwała złożona kompozycja farmaceutyczna
ZA201106651B (en) Composition comprising delivery particles
IL208387A0 (en) Pharmaceutical composition
EP2396037A4 (en) COMPOSITION WITH A BIODEGRADABLE CARRIER FOR THE CONTROLLED DISPOSAL OF MEDICAMENTS
GB201006818D0 (en) Drug delivery
EP2319503A4 (en) DRUG DELIVERY VECTOR
ZA201006224B (en) Pharmaceutical composition
GB2464200B (en) Pharmaceutical composition
GB0817969D0 (en) Pharmaceutical composition
GB0917792D0 (en) Delivery agent
GB0908685D0 (en) Composition for intraocular delivery
EP2236135A4 (en) STABLE PHARMACEUTICAL COMPOSITION
HK1166701A (en) Drug delivery composition